Compass Therapeutics | IPO Presentation Deck | 40 slides · page 30 of 40
The slide uses a biological diagram to contrast the efficacy of standard PD-1 inhibitors versus the proprietary CTX-8371 molecule.
Pitch deck · solution · present_solution · balanced density
Slide locked Sign in to view
Slide schematic 5/5
diagram 1/1 disclaimer 1/1 paragraph 2/2 title 1/1
Components 5
process disclaimer paragraph paragraph headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.